Delivery Order HHSO100201200012I-HHSO10033001T

This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to MedImmune LLC on September 12, 2013. The contract has a ceiling value of $5,625,000.00 and a period of performance through August 31, 2015. It was awarded under the Pandemic Influenza Preparedness and Response 2012-2016 master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract does not have a set-aside designation. As a...

This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to MedImmune LLC for $1,800,000.00. The contract is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle, which is used by ASPR to procure products and services related to pandemic preparedness. The contract has an ultimate completion date of October 31, 2018 and does...

This is a Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Medimmune LLC for the procurement of storage and stability study of live attenuated master and working seed lot(s) for preparedness and response. The contract has a ceiling value of $94,705.27 and a completion date of February 21, 2027. The contract is not set aside for any specific business type. This contract award is not associated with a...

This is a $19,471.20 fixed-price level of effort delivery order awarded to Seqirus Inc., a division of CSL Seqirus, by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The order is for the acquisition of medical countermeasures for pandemic influenza preparedness and response, and is placed under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract held by Seqirus with HHS ASPR. This...

This is a $19,134,687.00 definitive, firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to MedImmune Biologics, Inc. on December 18, 2015. The contract is for the 2016 Pandemic Influenza Preparedness program, with a period of performance ending on February 28, 2017. The contract does not have a set-aside designation. As the prime contractor, MedImmune Biologics, Inc. will be responsible for delivering the requested products and services under this contract....

This federal contract award is for $487,277.80 and was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of global biotechnology company CSL Seqirus. The contract is a delivery order under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC), a $13.4 billion vehicle that serves as the primary mechanism for Seqirus' federal contracting activities...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $849,451 firm fixed price delivery order to Protein Sciences Corporation under the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The delivery order is for the manufacture of master/working seed lot(s), research lot(s), and analytical laboratory testing/assay(s) to be performed in Meriden, Connecticut through June 2021. No subcontractors or set aside...

This contract award to Seqirus Inc., a division of the global biotechnology company CSL Seqirus, was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The $20,539,764.00 Delivery Order is for the "Acquisition of MCMS for Pandemic Influenza Preparedness and Response" and is part of a larger $13.4 billion Indefinite Delivery Contract (IDC) awarded to Seqirus in February 2022. Under this IDC, ASPR has...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Medimmune Biologics, Inc. for the supply of influenza virus vaccine. The contract has a ceiling value of $1,984.50 and a period of performance ending on July 25, 2022. The contract was awarded on October 9, 2014 and does not have a set-aside designation. As Medimmune Biologics, Inc. is a for-profit organization, they are the prime contractor on this contract, with no subcontractors mentioned....

This federal contract award was made by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The $18,890,210.47 fixed-price delivery order is for the acquisition of medical countermeasures for pandemic influenza preparedness and response. The contract is a task order under a larger $13.4 billion Indefinite Delivery Contract (IDC) awarded by HHS...